Financials

Discussions Technicals Seasonals

6814 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to LUKAS BIOMEDICAL INC operating, investing, and financing activities

6814 free cash flow for H2 24 is -40.64 M TWD. For 2024, 6814 free cash flow was -77.35 M TWD and operating cash flow was -70.53 M TWD.

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—